Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says
Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price increased by analysts at Cantor Fitzgerald from $99.00 to $132.00 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 145.63% from the stock’s […]
Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price increased by analysts at Cantor Fitzgerald from $99.00 to $132.00 in a note issued to investors on Tuesday, MarketBeat.com reports. The firm currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would suggest a potential upside of 145.63% from the stock’s […]
